Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Ebola outbreak in DRC ‘second worst in history’
The Ministry of Health recently announced that the first ever multi-drug Ebola trial will begin in DRC.
Country reports 440 cases since outbreak began

An Ebola outbreak in the Democratic Republic of the Congo (DRC) is the second largest in history, according to the World Health Organisation (WHO).

Peter Salama, WHO’s deputy director-general, said on Twitter last week: ‘The #Ebola outbreak in #DRC is now second largest historically. A sad toll, with too many families losing loved ones.

‘@WHO and partners will continue to stand shoulder-to-shoulder with @MinSanteRDC to do whatever it takes to bring the outbreak to an end.’

As of 1 December, there had been a total of 440 Ebola cases in DRC, with 392 confirmed and 48 probable. So far, 255 people have died since the outbreak was declared around five months ago.

WHO said responding to the outbreak continues to be a challenge, but the Ministry of Health, WHO and partners are focusing their activities in areas where transmission continues - in Butembo, Katwa, Beni and Kalunguta.

Community engagement remains difficult in Katwa, despite significant progress. Improvements are needed to address the high proportion of cases that were not previously registered as contacts and therefore not followed up by surveillance teams.

Insecurity in the eastern part of the country has also posed a challenge in responding to the Ebola threat. In September, health workers were forced to halt vaccinations and tracing people who had been in contact with suspected Ebola patients, owing to a deadly rebel attack.

In a recent statement, WHO said the risk of the outbreak spreading to other provinces in DRC, as well as to other countries, remains very high.

The Ministry of Health recently announced that the first ever multi-drug Ebola trial will begin in DRC, to evaluate the safety and efficacy of drugs.

“While our focus remains on bringing this outbreak to an end, the launch of the randomized control trial in DRC is an important step towards finally finding an Ebola treatment that will save lives,” said WHO director-general Dr Tedros Adhanom Ghebreyesus.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.